MATTHIAS DROSTEN-rekin lankidetzan egindako argitalpenak (2)

2022

  1. KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors

    Molecular Oncology, Vol. 16, Núm. 17, pp. 3066-3081

2021

  1. RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression

    Cancer Cell